Sodium Lauryl Sulfate (SLS) is a widely used anionic surfactant in cleansing formulations and one of the most frequently studied ingredients in dermatological research. Its long history as both a functional cleanser and a research reference compound has resulted in an extensive and sometimes conflicting evidence base.
As part of CleanFormulation’s periodic evidence review process, we reassessed published human patch-test data, concentration reporting, and regulatory commentary released through 2025. This page documents how newer findings affect the interpretation context of SLS and its ethoxylated form, Sodium Laureth Sulfate (SLES), across different product formats. For an explanation of how Sodium Lauryl Sulfate functions within dishwashing liquids, hand soaps, and laundry detergents, see our ingredient function and formulation overview .
Summary of the 2025 Evidence Review
Recent human patch-test literature and regulator commentary show increased consistency in reported irritation outcomes for rinse-off formulations using SLS or SLES at lower active surfactant concentrations. Based on this convergence, the interpretive flag applied to typical rinse-off use contexts has been adjusted to reflect a higher level of tolerance reported in controlled exposure studies.
For leave-on or high-residue formats, interpretation remains more conservative. Available data continue to show greater variability in irritation responses under conditions of prolonged skin contact.
Evidence Inputs Considered
- Human patch-test studies: 12 studies (2018–2025), total n = 1,340 participants
- Reported concentration ranges: 0.5%–5% active SLS/SLES equivalents
- Exposure context: rinse-off vs prolonged contact models
- Regulatory publications: EU SCCS commentary (2025), CIR addendum (2024)
What Changed in the Interpretation
A large, multi-site human patch-test study published by Smith et al. (2025) introduced improved reproducibility controls and broader population sampling than earlier datasets. When integrated with existing literature, the updated dataset showed lower cumulative irritation scores at reduced exposure durations and concentrations commonly reported for rinse-off products.
Earlier studies were retained in the analysis but down-weighted where reporting standards, exposure realism, or reproducibility metrics were limited.
Scientific Context
SLS (C12H25OSO3Na) is a small-molecule anionic surfactant derived from lauric acid. Its interaction with the stratum corneum is concentration-dependent and strongly influenced by contact time, formulation matrix, and co-surfactant systems.
Historically, SLS has been used as a reference irritant in dermatological testing because of its predictable dose-response behavior. Contemporary consumer formulations, however, typically employ lower active concentrations and combine SLS or SLES with amphoteric or non-ionic surfactants to modify skin interaction. A detailed breakdown of how these formulation differences appear across cleaning products is discussed in our SLS formulation role across dish, hand, and laundry systems .
How This Page Was Assessed
This review follows the CleanFormulation Evidence Model, which weights peer-reviewed human data, regulatory publications, and reproducibility checks. Each source was evaluated for study design, exposure relevance, and reporting quality. Changes were logged and versioned to maintain traceability.
Version History
- v1.2 – Nov 2025: Updated human patch-test synthesis; interpretive context adjusted for rinse-off use.
- v1.1 – May 2024: Dataset expansion; no interpretive change.
- v1.0 – Jan 2023: Initial documentation.
Context note: CleanFormulation does not provide medical, regulatory, or usage advice and does not endorse products. This page documents how published research and regulatory material are interpreted within our framework. Individual responses to ingredients vary and are outside the scope of this documentation.